Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melmed

Showing results (741-750 of 800) with videos related to

Pageof 80
Sort By:
Pituitary|January 29, 2025
Medical management pathways for Cushing's disease in pituitary tumors centers of excellence (PTCOEs)A Giustina, M M Uygur, S Frara, et al.
Human Molecular Genetics|June 24, 2010
Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's diseaseDermot P B McGovern, Michelle R Jones, Kent D Taylor, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2004
Mapping of sudden infant death with dysgenesis of the testes syndrome (SIDDT) by a SNP genome scan and identification of TSPYL loss of functionErik G Puffenberger, Diane Hu-Lince, Jennifer M Parod, et al.
Inflammatory Bowel Diseases|May 17, 2017
Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel DiseaseGeoffrey C Nguyen, Karen Boland, Waqqas Afif, et al.
World Journal of Gastrointestinal Surgery|April 5, 2024
Pre-operative visceral adipose tissue radiodensity is a potentially novel prognostic biomarker for early endoscopic post-operative recurrence in Crohn's diseasePhillip Gu, Shishir Dube, Norman Gellada, et al.
Pituitary|June 4, 2024
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)Andrea Giustina, M M Uygur, S Frara, et al.
Molecular Psychiatry|April 24, 2001
Reelin gene alleles and haplotypes as a factor predisposing to autistic disorderA M Persico, L D'Agruma, N Maiorano, et al.
Pituitary|August 28, 2023
Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centersA Giustina, M M Uygur, S Frara, et al.
Alimentary Pharmacology & Therapeutics|June 3, 2015
Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7-year PRECiSE 3 studyW J Sandborn, G Y Melmed, D P B McGovern, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 19, 2016
Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of ResultsGil Y Melmed, Peter M Irving, Jennifer Jones, et al.
Pageof 80

Showing results (741-750 of 800) with videos related to

Sort By:
Pageof 80
Pituitary|January 29, 2025
Medical management pathways for Cushing's disease in pituitary tumors centers of excellence (PTCOEs)A Giustina, M M Uygur, S Frara, et al.
Human Molecular Genetics|June 24, 2010
Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's diseaseDermot P B McGovern, Michelle R Jones, Kent D Taylor, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2004
Mapping of sudden infant death with dysgenesis of the testes syndrome (SIDDT) by a SNP genome scan and identification of TSPYL loss of functionErik G Puffenberger, Diane Hu-Lince, Jennifer M Parod, et al.
Inflammatory Bowel Diseases|May 17, 2017
Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel DiseaseGeoffrey C Nguyen, Karen Boland, Waqqas Afif, et al.
World Journal of Gastrointestinal Surgery|April 5, 2024
Pre-operative visceral adipose tissue radiodensity is a potentially novel prognostic biomarker for early endoscopic post-operative recurrence in Crohn's diseasePhillip Gu, Shishir Dube, Norman Gellada, et al.
Pituitary|June 4, 2024
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)Andrea Giustina, M M Uygur, S Frara, et al.
Molecular Psychiatry|April 24, 2001
Reelin gene alleles and haplotypes as a factor predisposing to autistic disorderA M Persico, L D'Agruma, N Maiorano, et al.
Pituitary|August 28, 2023
Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centersA Giustina, M M Uygur, S Frara, et al.
Alimentary Pharmacology & Therapeutics|June 3, 2015
Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7-year PRECiSE 3 studyW J Sandborn, G Y Melmed, D P B McGovern, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 19, 2016
Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of ResultsGil Y Melmed, Peter M Irving, Jennifer Jones, et al.
Pageof 80